We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

34 hedge funds and large institutions have $18.3M invested in VolitionRx Ltd in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

47% more call options, than puts

Call options by funds: $192K | Put options by funds: $131K

0.01% more ownership

Funds ownership: 0.56% → 0.57% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $18.7M → $18.3M (-$401K)

6% less funds holding

Funds holding: 36 → 34 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
34
Holders Change
-2
Holders Change %
-5.56%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
10
Reduced
5
Closed
4
Calls
$192K
Puts
$131K
Net Calls
+$61K
Net Calls Change
+$218K

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$301K
2
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$53.8K
3
Citadel Advisors
Citadel Advisors
Florida
+$43.1K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$37.7K
5
State Street
State Street
Massachusetts
+$29.8K

Top Sellers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
-$51K
2
E
Ergoteles
New York
-$50K
3
Renaissance Technologies
Renaissance Technologies
New York
-$35K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$34.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$17.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$10.2M +$301K +5,316 +3%
BlackRock
2
BlackRock
New York
$1.65M +$16K +282 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.51M -$17.9K -315 -1%
Morgan Stanley
4
Morgan Stanley
New York
$1.44M +$27.9K +492 +2%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$851K +$37.7K +666 +5%
BCM
6
Bridgeway Capital Management
Texas
$726K – – –
State Street
7
State Street
Massachusetts
$347K +$29.8K +525 +10%
CPA
8
Cowen Prime Advisors
New York
$225K +$28.9K +510 +16%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$195K -$34.1K -601 -16%
Northern Trust
10
Northern Trust
Illinois
$190K – – –
Millennium Management
11
Millennium Management
New York
$171K -$16.6K -293 -9%
SAMC
12
Spectrum Asset Management (California)
California
$167K – – –
Barclays
13
Barclays
United Kingdom
$89K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$79K +$43.1K +760 +139%
CAPTRUST Financial Advisors
15
CAPTRUST Financial Advisors
North Carolina
$75K +$53.8K +950 +317%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$67K – – –
Bank of New York Mellon
17
Bank of New York Mellon
New York
$66K – – –
Charles Schwab
18
Charles Schwab
California
$47K – – –
GBA
19
Garrison Bradford & Associates
New York
$47K – – –
UBS Group
20
UBS Group
Switzerland
$18K +$11.3K +199 +212%
Simplex Trading
21
Simplex Trading
Illinois
$15K -$10K -177 -41%
HFM
22
Hartford Financial Management
Connecticut
$15K – – –
Credit Agricole
23
Credit Agricole
France
$12K – – –
Bank of America
24
Bank of America
North Carolina
$12K +$7.14K +126 +164%
Osaic Holdings
25
Osaic Holdings
Arizona
$10K – – –
1
2

VNRX Hedge Fund Activity: Q1 2022 in Review

34 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2022, worth a combined $18.3M — down 2.1% from $18.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VNRX and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Lagoda Investment Management, adding an estimated $301K. The largest seller was Creative Planning, exiting entirely with an estimated $51K sold.

  • 34 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2022, down from 36 in Q4 2021.
  • Funds reported $18.3M of VolitionRx Ltd stock for Q1 2022, down 2.1% quarter-over-quarter.
  • 2 funds opened new VolitionRx Ltd positions in Q1 2022 and 4 closed out, a net change of -2 holders.
  • The largest VolitionRx Ltd buyer in Q1 2022 was Lagoda Investment Management, an estimated $301K added.
  • The largest VolitionRx Ltd seller in Q1 2022 was Creative Planning, an estimated $51K sold.

Based on aggregated 13F filings for Q1 2022.